PlainRecalls
FDA Devices Low Class III Terminated

Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision of laboratory testing procedures for HbA1c quantitation.

Reported: December 19, 2018 Initiated: October 5, 2018 #Z-0601-2019

Product Description

Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision of laboratory testing procedures for HbA1c quantitation.

Reason for Recall

Tosoh Bioscience has become aware of potential degradation of HbA1c control lot # 7055 before the 60-days product stability claim. If degradation of these controls occurs, P00 peaks may be seen and the % HbA1c control values may drift higher than the assigned range. This may result in delays when performing routine instrument quality control. If this issue occurs, there may be a delay in testing and reporting patient test results. Tosoh has received two (2) complaints related to this issue with no serious injuries reported.

Details

Recalling Firm
Tosoh Bioscience Inc
Units Affected
1000
Distribution
Distributed nationwide. Foreign distribution to Canada.
Location
Grove City, OH

Frequently Asked Questions

What product was recalled?
Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision of laboratory testing procedures for HbA1c quantitation.. Recalled by Tosoh Bioscience Inc. Units affected: 1000.
Why was this product recalled?
Tosoh Bioscience has become aware of potential degradation of HbA1c control lot # 7055 before the 60-days product stability claim. If degradation of these controls occurs, P00 peaks may be seen and the % HbA1c control values may drift higher than the assigned range. This may result in delays when performing routine instrument quality control. If this issue occurs, there may be a delay in testing and reporting patient test results. Tosoh has received two (2) complaints related to this issue with no serious injuries reported.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 19, 2018. Severity: Low. Recall number: Z-0601-2019.